ANIP logo

ANI Pharmaceuticals, Inc. Stock Price

NasdaqGM:ANIP Community·US$2.0b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

ANIP Share Price Performance

US$95.12
35.84 (60.46%)
23.5% overvalued intrinsic discount
US$77.00
Fair Value
US$95.12
35.84 (60.46%)
23.5% overvalued intrinsic discount
US$77.00
Fair Value
Price US$95.12
AnalystLowTarget US$77.00
AnalystHighTarget US$120.00
AnalystConsensusTarget US$105.00

ANIP Community Narratives

AnalystLowTarget·
Fair Value US$77 23.5% overvalued intrinsic discount

Pharmaceutical Pricing Pressures Will Erode Margins Amid Tighter Controls

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value US$120 20.7% undervalued intrinsic discount

Emerging Markets And Aging Populations Will Expand Patient Access

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$105 9.4% undervalued intrinsic discount

Expanding ACTH Potential And Rare Disease Markets Will Evolve

0users have liked this narrative
1users have commented on this narrative
3users have followed this narrative
US$77
23.5% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
9.31% p.a.
Profit Margin
10.19%
Future PE
19.78x
Share price in 2028
US$89.86

Snowflake Analysis

Undervalued with reasonable growth potential.

1 Risk
3 Rewards

ANI Pharmaceuticals, Inc. Key Details

US$747.4m

Revenue

US$291.0m

Cost of Revenue

US$456.4m

Gross Profit

US$469.1m

Other Expenses

-US$12.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.61
61.06%
-1.70%
134.7%
View Full Analysis

About ANIP

Founded
2001
Employees
897
CEO
Nikhil Lalwani
WebsiteView website
www.anipharmaceuticals.com

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Recent ANIP News & Updates

Recent updates

No updates